Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

0
Brompton Announces Special Meetings of Dividend Growth Split Corp. and Brompton Split Banc Corp.

2018-07-16 globenewswire
TORONTO, July 16, 2018 (GLOBE NEWSWIRE) -- (TSX:DGS) (TSX:DGS.PR.A) (TSX:SBC) (TSX:SBC.PR.A) Brompton Funds Limited (“Brompton” or the “Manager”), announces special meetings (the “Meetings” and each, a “Meeting”) of holders of Class A Shares and Preferred Shares (the “Shareholders”) of Dividend Growth Split Corp. (“DGS”) and Brompton Split Banc Corp (“SBC”). The purpose of the Meetings is to consider and vote upon extraordinary resolutions to implement amendments to update and modernize the investment objectives, investment strategies and investment restrictions of DGS and SBC (the “Amendments”).
TNTTF DGS DGS.PR.A SBC.PR.A TXCX SBC TD TD

0
Crude’s bull run made this oilsands producer Canada’s top stock

2018-07-13 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
CNQ MEG TXCX MEGEF CEO SU SU

100
Big money tests marijuana waters, with hedge funds leading charge

2018-07-12 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
STZ.B KHRNF RCI ACBFF DTK TXCX STZ CGC RCIAF TWMJF ACB BLK APH WEED APHQF OGRMF GWP OGI

0
Crude's bull run made this oil-sands producer Canada's top stock

2018-07-12 worldoil
CALGARY (Bloomberg) -- For any investor who was looking to gain from rising oil prices, there may not have been a better way to play the recent bull run than MEG Energy Corp.
CNQ MEG TXCX MEGEF SU SU

5
Bombardier Rallies to Lead Aerospace on Airbus Deal, Luxury Jets - Bloomberg

2018-07-11 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
JBK GS.PRICL GSC TFG GS.PRB GS.PRA JBLU TXCX GSJ GS.PRJ GS.PRI GS GLSSP GS.PRD GS.PRC BDRPF GJS GS.PRN GS.PRK

0
Canadian General Investments: Investment Update - Unaudited

2018-07-05 globenewswire
TORONTO, July 05, 2018 (GLOBE NEWSWIRE) -- Canadian General Investments, Limited (CGI) (TSX:CGI) (TSX:CGI.PR.D) (LSE:CGI) reports on an unaudited basis that its net asset value per share (NAV) at June 30, 2018 was $35.73, resulting in year-to-date and 12-month NAV returns, with dividends reinvested, of 9.0% and 26.6%, respectively. These compare with the 1.9% and 10.4% returns of the benchmark S&P/TSX Composite Index on a total return basis for the same periods.
CGI TXCX CGI CGRIF

0
Life & Banc Split Corp. Completes Treasury Offering

2018-07-04 globenewswire
TORONTO, July 04, 2018 (GLOBE NEWSWIRE) -- Life & Banc Split Corp. (the “Company”) (TSX:LBS) (TSX:LBS.PR.A) is pleased to announce that it has completed the previously announced treasury offering of class A shares and preferred shares (the “Class A Shares” and “Preferred Shares”, respectively) for aggregate gross proceeds of approximately $50.1 million. The Class A Shares and Preferred Shares will continue to trade on the Toronto Stock Exchange under the existing symbols LBS (Class A Shares) and LBS.
LBS TXCX

0
What trade war? Strategists get more bullish on Canadian stocks

2018-07-03 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
FSZ MEG TXCX MEGEF

44
Legal Marijuana, Oil Send Canadian Stocks to Record High - Bloomberg

2018-06-20 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
TWMJF GOOS SHOP WEED MEG TXCX MEGEF CGC

25
Marijuana Stocks Surge on Canadian Senate Approval of Legalization - Bloomberg

2018-06-20 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
TWMJF ACB APH WEED ACBFF TXCX APHQF CGC

0
Life & Banc Split Corp. Announces Successful Overnight Offering

2018-06-20 globenewswire
TORONTO, June 20, 2018 (GLOBE NEWSWIRE) -- Life & Banc Split Corp. (the “Company”) (TSX:LBS) (TSX:LBS.PR.A) is pleased to announce a successful overnight treasury offering of class A and preferred shares (the “Class A Shares” and “Preferred Shares”, respectively). Gross proceeds of the offering are expected to be approximately $50.1 million. The offering is expected to close on or about July 4, 2018 and is subject to certain closing conditions including approval by the Toronto Stock Exchange (the “TSX”).
LBS TXCX

0
Life & Banc Split Corp. Announces Overnight Offering

2018-06-19 globenewswire
TORONTO, June 19, 2018 (GLOBE NEWSWIRE) -- Life & Banc Split Corp. (TSX:LBS) (TSX:LBS.PR.A) (the “Company”) is pleased to announce it is undertaking an overnight treasury offering of class A and preferred shares (the “Class A Shares” and “Preferred Shares”, respectively).
LBS TXCX

14
CANADA STOCKS-TSX rises as higher oil prices boost energy shares

2018-06-18 reuters
June 18 (Reuters) - Canada’s main stock index rose on Monday, boosted by the energy sector which climbed higher after a gain in oil prices.
GOOS VRX RRENF SOUHY TXCX BTE SHTLF RRX

0
CANADA STOCKS-TSX opens lower on U.S.-China trade war fears

2018-06-18 reuters
June 18 (Reuters) - Canada’s main stock index opened lower on Monday on fears of an escalating trade war between the United States and China.
TXCX

45
CANADA STOCKS-TSX advances as financial stocks rise

2018-06-04 reuters
June 4 (Reuters) - Canada’s main stock index climbed higher on Monday, led by the heavyweight financial sector and consumer discretionary stocks.
TAHO FXFLF TNTTF FXFHF NXGEF FAXXF TXCX FRFHF FRFGF CGC TD FRFFF NSU TWMJF THO NXE WEED FRFZF FAXRF FRFXF TD

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

15h - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

17h - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...